A worldwide leader in respiratory drug delivery devices for the treatment of asthma and COPD, Aptar Pharma will exhibit at Booth 432 at DDL, where their team of experts will showcase their innovative range of respiratory drug delivery systems and connected devices that help improve adherence and patient health outcomes.
Noble International, a global leader in drug delivery device trainers and patient onboarding and the latest addition to the Aptar Pharma family, will also be on exhibit at Booth 432.
Also exhibiting at Booth 432 will be Aptar CSP Technologies, the active packaging specialists.
Aptar Pharma’s newly expanded Aptar Pharma Services platform will also be highlighted at DDL 2019. Leading experts from Aptar Pharma companies Nanopharm, Next Breath and Gateway Analytical will be on hand at the following Booths to discuss how their value-added services can help customers accelerate and derisk their drug development journey:
• Nanopharm will exhibit at Booth 518
• Next Breath will exhibit at Booth 516
• Gateway Analytical will exhibit at Booth 514.
To further share its expertise in respiratory drug delivery with the scientific community, Aptar Pharma will be presenting five scientific posters, during DDL 2019. Delegates and attendees will have the opportunity to view them during the dedicated poster sessions, which will take place daily at the Conference.
Guillaume Brouet, Vice-President Regulatory, Analytical & Scientific Affairs at Aptar Pharma, commented, “As a leader in inhalation drug delivery systems, we are proud to be a Platinum Sponsor of DDL this year. We look forward to showcasing our expanded Aptar Pharma device, technologies and services offering, which provide complete solutions for customers and further support their respiratory drug development journeys”.
Aptar Pharma is also a sponsor of the special DDL 2019 Dinner celebrating DDL’s 30th Anniversary, which will take place on Thursday, December 12th and to which all delegates and exhibitors are invited.
